Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:212439rdf:typepubmed:Citationlld:pubmed
pubmed-article:212439lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:212439lifeskim:mentionsumls-concept:C0018062lld:lifeskim
pubmed-article:212439lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:212439lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:212439lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:212439lifeskim:mentionsumls-concept:C0243125lld:lifeskim
pubmed-article:212439lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:212439lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:212439lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:212439lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:212439lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:212439pubmed:issue21lld:pubmed
pubmed-article:212439pubmed:dateCreated1978-12-20lld:pubmed
pubmed-article:212439pubmed:abstractTextResults presented in the previous paper (Ascoli, M., and Puett, D. (1978) J. Biol. Chem. 253, 7832--7838) show that the degradation of receptor-bound 125I-labeled human choriogonadotropin can be inhibited by chloroquine, protease inhibitors, and metabolic inhibitors. These compounds were also shown to inhibit gonadotropin-stimulated steroidogenesis. It is reported herein that these inhibitors also block the stimulation of steroidogenesis by both cholera toxin and 8-Br-adenosine 3':5'-monophosphate, thus showing that they are not specific for the hormonal stimuli. These results, taken together with previous observations that show that NH2Cl can block hormone degradation without inhibiting hormone-stimulated steroidogenesis, strongly suggest that the degradation of choriogonadotropin is not required for its stimulatory action on progesterone production.lld:pubmed
pubmed-article:212439pubmed:languageenglld:pubmed
pubmed-article:212439pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:212439pubmed:citationSubsetIMlld:pubmed
pubmed-article:212439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:212439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:212439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:212439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:212439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:212439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:212439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:212439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:212439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:212439pubmed:statusMEDLINElld:pubmed
pubmed-article:212439pubmed:monthNovlld:pubmed
pubmed-article:212439pubmed:issn0021-9258lld:pubmed
pubmed-article:212439pubmed:authorpubmed-author:AscoliMMlld:pubmed
pubmed-article:212439pubmed:issnTypePrintlld:pubmed
pubmed-article:212439pubmed:day10lld:pubmed
pubmed-article:212439pubmed:volume253lld:pubmed
pubmed-article:212439pubmed:ownerNLMlld:pubmed
pubmed-article:212439pubmed:authorsCompleteYlld:pubmed
pubmed-article:212439pubmed:pagination7839-43lld:pubmed
pubmed-article:212439pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-A...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-M...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-C...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-S...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-A...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-C...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-M...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-K...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-C...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-P...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-L...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-R...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-D...lld:pubmed
pubmed-article:212439pubmed:meshHeadingpubmed-meshheading:212439-D...lld:pubmed
pubmed-article:212439pubmed:year1978lld:pubmed
pubmed-article:212439pubmed:articleTitleDemonstration of a direct effect of inhibitors of the degradation of receptor-bound human choriogonadotropin on the steroidogenic pathway.lld:pubmed
pubmed-article:212439pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:212439pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:212439lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:212439lld:pubmed